Daraxonrasib belongs to a new class of medicines known as RAS(ON) inhibitors. The drug targets the active form of RAS proteins, which help drive tumour growth and survival. Pancreatic cancer is one of the most severe, aggressive, and deadly forms of cancer with a high mortality rate. Research over the years indicates that pancreatic cancer is exceptionally difficult to detect early and is highly resistant to standard tr... [7442 chars]
ADVERTISEMENT
ADVERTISEMENT
2026 Copyright © News-Matic.com. All Rights Reserved
